1. Home
  2. RILYP vs YDESW Comparison

RILYP vs YDESW Comparison

Compare RILYP & YDESW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RILYP

B. Riley Financial Inc.

HOLD

Current Price

$11.75

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

YDESW

YD Bio Limited Warrants

N/A

Current Price

$0.46

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RILYP
YDESW
Founded
1973
N/A
Country
United States
United States
Employees
2056
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RILYP
YDESW
Price
$11.75
$0.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.1K
12.7K
Earning Date
01-01-0001
N/A
Dividend Yield
7.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$854,383,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$0.36
52 Week High
$14.50
$2.85

Technical Indicators

Market Signals
Indicator
RILYP
YDESW
Relative Strength Index (RSI) 56.77 36.44
Support Level $8.56 $0.36
Resistance Level $12.74 $0.76
Average True Range (ATR) 0.80 0.07
MACD -0.05 -0.01
Stochastic Oscillator 49.03 3.50

Price Performance

Historical Comparison
RILYP
YDESW

About RILYP B. Riley Financial Inc.

BRC Group Holdings Inc is a diversified holding company, including financial services, telecom, and retail, and investments in equity, debt and venture capital.

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: